Mallinckrodt Ireland Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MALLINCKRODT IRELAND, and when can generic versions of MALLINCKRODT IRELAND drugs launch?
MALLINCKRODT IRELAND has one approved drug.
There is one US patent protecting MALLINCKRODT IRELAND drugs.
There are twenty-three patent family members on MALLINCKRODT IRELAND drugs in fourteen countries.
Summary for Mallinckrodt Ireland
| International Patents: | 23 |
| US Patents: | 1 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Mallinckrodt Ireland
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mallinckrodt Ireland | TERLIVAZ | terlipressin acetate | POWDER;INTRAVENOUS | 022231-001 | Sep 14, 2022 | RX | Yes | Yes | 10,335,452 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Mallinckrodt Ireland | TERLIVAZ | terlipressin acetate | POWDER;INTRAVENOUS | 022231-001 | Sep 14, 2022 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Mallinckrodt Ireland | TERLIVAZ | terlipressin acetate | POWDER;INTRAVENOUS | 022231-001 | Sep 14, 2022 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Mallinckrodt Ireland Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 2022171795 | ⤷ Try a Trial |
| Japan | 2017534618 | ⤷ Try a Trial |
| Japan | 6989571 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
